MOS and metabolic dysfunction-associated steatohepatitis: Considering the hypermetabolic state of circulating Mos in patients with MASH and the possibility of targeting their mitochondrial metabolism and the energy metabolism pathway profiles in Mos and LAMs of murine MASH liver, we investigated the in vivo potential effect of DMM in a mouse model of MASH.